DSI
MYOK

Daiwa SB Investments’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Daiwa SB Investments’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,240
Closed -$82K – 257
2017
Q2 		$82K Sell
6,240
-6,725
-52% -$88.6K 0.02% 167
2017
Q1 		$170K Buy
+12,965
New +$166K 0.05% 137

Other funds holding MYOK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Daiwa SB Investments's MYOK Position: Q3 2017 in Review

Daiwa SB Investments sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2017, closing a stake of 6,240 shares — an estimated $82K sold.

Daiwa SB Investments first reported a position in MYOK in Q1 2017 and held it in 2 quarters. The position peaked at $170K in Q1 2017. 115 funds tracked by Wall St. Rank hold MYOK as of Q3 2017.

  • Daiwa SB Investments reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Daiwa SB Investments sold 6,240 MyoKardia, Inc. Common Stock shares in Q3 2017, an estimated $82K.
  • Daiwa SB Investments first reported a position in MyoKardia, Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • Daiwa SB Investments's MyoKardia, Inc. Common Stock position peaked at $170K in Q1 2017.
  • 115 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2017.

Based on Daiwa SB Investments's 13F filing for Q3 2017, filed 13 Oct 2017.